Integra Lifesciences Holdings (IART) Net Equity Issued and Repurchased (2015 - 2018)
Integra Lifesciences Holdings' (IART) quarterly Net Equity Issued and Repurchased came in at -$9000.0 in Q3 2018, up 95.89% quarter-over-quarter from -$219000.0 in Q4 2015.
Powered by 
Analysis
Integra Lifesciences Holdings (IART) Net Equity Issued and Repurchased (2015 - 2018) Analysis & Trends
Integra Lifesciences Holdings has disclosed Net Equity Issued and Repurchased across 2 years of filings, most recently posting -$9000.0 for Q3 2018.
- In Q3 2018, Net Equity Issued and Repurchased changed N/A year-over-year to -$9000.0; the TTM figure through Dec 2019 stood at -$9000.0 (changed 0.0% YoY), while the FY2018 annual figure was $349.6 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased came in at -$9000.0 for Q3 2018 at Integra Lifesciences Holdings, up from -$219000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of -$9000.0 in Q3 2018 to a low of -$219000.0 in Q4 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 20.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Integra Lifesciences Holdings | 1.25 Bn | 977.26 Mn | 219.74 Mn | - |